[PDF][PDF] Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
…, JN Wohlstadter, MM Davis, B Pulendran, ML Troxell… - Cell, 2022 - cell.com
During the SARS-CoV-2 pandemic, novel and traditional vaccine strategies have been
deployed globally. We investigated whether antibodies stimulated by mRNA vaccination (…
deployed globally. We investigated whether antibodies stimulated by mRNA vaccination (…
[HTML][HTML] Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
FB Cortazar, KA Marrone, ML Troxell, KM Ralto… - Kidney international, 2016 - Elsevier
Immune checkpoint inhibitors (CPIs), monoclonal antibodies that target inhibitory receptors
expressed on T cells, represent an emerging class of immunotherapy used in treating solid …
expressed on T cells, represent an emerging class of immunotherapy used in treating solid …
[HTML][HTML] Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients
…, WF Symmans, O Tawfik, D Tripathy, ML Troxell… - The Lancet …, 2022 - thelancet.com
Background Previous studies have independently validated the prognostic relevance of
residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several …
residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several …
Identification of recurrent SMO and BRAF mutations in ameloblastomas
…, T Sugiyama, S Koyota, BP Rubin, ML Troxell… - Nature …, 2014 - nature.com
Here we report the discovery of oncogenic mutations in the Hedgehog and mitogen-activated
protein kinase (MAPK) pathways in over 80% of ameloblastomas, locally destructive …
protein kinase (MAPK) pathways in over 80% of ameloblastomas, locally destructive …
Multicenter clinicopathologic correlation of kidney biopsies performed in COVID-19 patients presenting with acute kidney injury or proteinuria
…, M Yamashita, K Henriksen, V Charu, ML Troxell… - American Journal of …, 2021 - Elsevier
Rationale & Objective Kidney biopsy data inform us about pathologic processes associated
with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We …
with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We …
Tuberous sclerosis–associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients
J Guo, MS Tretiakova, ML Troxell… - The American journal …, 2014 - journals.lww.com
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder with characteristic
tumors involving multiple organ systems. Whereas renal angiomyolipoma (AML) is common in …
tumors involving multiple organ systems. Whereas renal angiomyolipoma (AML) is common in …
[HTML][HTML] Early prediction and evaluation of breast cancer response to neoadjuvant chemotherapy using quantitative DCE-MRI
A Tudorica, KY Oh, SYC Chui, N Roy, ML Troxell… - Translational …, 2016 - Elsevier
The purpose is to compare quantitative dynamic contrast-enhanced (DCE) magnetic
resonance imaging (MRI) metrics with imaging tumor size for early prediction of breast cancer …
resonance imaging (MRI) metrics with imaging tumor size for early prediction of breast cancer …
Assessment of residual cancer burden and event-free survival in neoadjuvant treatment for high-risk breast cancer: an analysis of data from the I-SPY2 randomized …
…, IT Ocal, F Fan, LG LeBeau, T Vinh, ML Troxell… - JAMA …, 2021 - jamanetwork.com
Importance Residual cancer burden (RCB) distributions may improve the interpretation of
efficacy in neoadjuvant breast cancer trials. Objective To compare RCB distributions between …
efficacy in neoadjuvant breast cancer trials. Objective To compare RCB distributions between …
Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma
…, MC Heinrich, CL Corless, ML Troxell - Breast cancer research …, 2010 - Springer
Mutationally activated protein kinases are appealing therapeutic targets in breast carcinoma.
Mutations in phosphatidylinositol-3-kinase (PI3KCA) have been described in 8–40% of …
Mutations in phosphatidylinositol-3-kinase (PI3KCA) have been described in 8–40% of …
[HTML][HTML] High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast
ML Troxell, J Levine, C Beadling, A Warrick, J Dunlap… - Modern pathology, 2010 - Elsevier
Papillary lesions of the breast have an uncertain relationship to the histogenesis of breast
carcinoma, and are thus diagnostically and managerially challenging. Molecular genetic …
carcinoma, and are thus diagnostically and managerially challenging. Molecular genetic …